Expression profiling predicts outcome in breast cancer

被引：130

作者：

van 't Veer, LJ

Dai, HY

van de Vijver, MJ

He, YDD

Hart, AAM

Bernards, R

Friend, SH

机构：

[1] Netherlands Canc Inst, Div Diagnost Oncol, NL-1066 CX Amsterdam, Netherlands

[2] Netherlands Canc Inst, Ctr Biomed Genet, Amsterdam, Netherlands

[3] Rosetta Inpharmat Inc, Kirkland, WA USA

[4] Netherlands Canc Inst, Div Radiotherapy, Amsterdam, Netherlands

[5] Netherlands Canc Inst, Div Mol Carcinogenesis, Amsterdam, Netherlands

来源：

BREAST CANCER RESEARCH | 2003年 / 5卷 / 01期

关键词：

Breast Cancer; Estrogen Receptor Status; Tamoxifen Treatment; cDNA Array; Adjuvant Systemic Therapy;

D O I：

10.1186/bcr562

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：57 / 58

页数：2

共 3 条

[1]

Gruvberger S, 2001, CANCER RES, V61, P5979

[2] Expression profiling to predict outcome in breast cancer:: the influence of sample selection [J].

Gruvberger, SK ;

Ringnér, M ;

Edén, P ;

Borg, Å ;

Fernö, M ;

Peterson, C ;

Meltzer, PS .

BREAST CANCER RESEARCH, 2003, 5 (01) :23-26

[3] Gene expression profiling predicts clinical outcome of breast cancer [J].

van't Veer, LJ ;

Dai, HY ;

van de Vijver, MJ ;

He, YDD ;

Hart, AAM ;

Mao, M ;

Peterse, HL ;

van der Kooy, K ;

Marton, MJ ;

Witteveen, AT ;

Schreiber, GJ ;

Kerkhoven, RM ;

Roberts, C ;

Linsley, PS ;

Bernards, R ;

Friend, SH .

NATURE, 2002, 415 (6871) :530-536

← 1 →